June 26, 2010
Teva sabotaged drug to save Copaxone sales, claims ProNeuron
Teva sabotaged drug to save Copaxone sales, claims ProNeuron
Teva Pharmaceuticals (TASE, Nasdaq: TEVA ) is not only hurting ProNeuron Biotechnologies and its rights. It’s hurting the public of patients suffering from neuro-degenerative diseases.
Read more on Haaretz Daily
Filed under Weight Loss by on Jun 26th, 2010. 
Leave a Comment